129 related articles for article (PubMed ID: 10617250)
1. Efficacy and safety of a constant-estrogen, pulsed-progestin regimen in hormone replacement therapy.
Sulak PJ; Caubel P; Lane R
Int J Fertil Womens Med; 1999; 44(6):286-96. PubMed ID: 10617250
[TBL] [Abstract][Full Text] [Related]
2. Effect of a unique constant-estrogen, pulsed-progestin hormone replacement therapy containing 17beta-estradiol and norgestimate on endometrial histology.
Corson SL; Richart RM; Caubel P; Lim P
Int J Fertil Womens Med; 1999; 44(6):279-85. PubMed ID: 10617249
[TBL] [Abstract][Full Text] [Related]
3. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
4. Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.
Ylikorkala O; Wahlström T; Caubel P; Lane R
Acta Obstet Gynecol Scand; 2002 Jul; 81(7):654-60. PubMed ID: 12190841
[TBL] [Abstract][Full Text] [Related]
5. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
Gynecol Endocrinol; 2001 Oct; 15(5):349-58. PubMed ID: 11727357
[TBL] [Abstract][Full Text] [Related]
6. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
7. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
8. Effects of E2 and E2/norgestimate hormone therapy on elevated baseline lipids.
Langer RD; Friedman AJ
J Reprod Med; 2006 Aug; 51(8):610-6. PubMed ID: 16967629
[TBL] [Abstract][Full Text] [Related]
9. Use of low-dosage 17 beta-estradiol for the prevention of osteoporosis.
Ettinger B
Clin Ther; 1993; 15(6):950-62; discussion 949. PubMed ID: 8111815
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
Archer DF; Thorneycroft IH; Foegh M; Hanes V; Glant MD; Bitterman P; Kempson RL
Menopause; 2005; 12(6):716-27. PubMed ID: 16278615
[TBL] [Abstract][Full Text] [Related]
11. A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate.
Neven P; Lunde T; Benedetti-Panici P; Tiitinen A; Marinescu B; de Villiers T; Hillard T; Cano A; Peer E; Quail D; Nickelsen T;
BJOG; 2003 Feb; 110(2):157-67. PubMed ID: 12618160
[TBL] [Abstract][Full Text] [Related]
12. Norgestimate. From the laboratory to three clinical indications.
Henzl MR
J Reprod Med; 2001 Jul; 46(7):647-61. PubMed ID: 11499185
[TBL] [Abstract][Full Text] [Related]
13. Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms.
Rozenberg S; Caubel P; Lim PC
Int J Gynaecol Obstet; 2001 Mar; 72(3):235-43. PubMed ID: 11226444
[TBL] [Abstract][Full Text] [Related]
14. Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women.
Curran MP; Wagstaff AJ
Treat Endocrinol; 2002; 1(2):127-9. PubMed ID: 15765628
[TBL] [Abstract][Full Text] [Related]
15. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
[TBL] [Abstract][Full Text] [Related]
16. Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen.
Rozenberg S; Pornel B; Koninckx PR; Palacios S; Christiansen C
Hum Reprod; 2009 Jul; 24(7):1739-47. PubMed ID: 19351658
[TBL] [Abstract][Full Text] [Related]
17. Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women.
Curran MP; Wagstaff AJ
Drugs Aging; 2001; 18(11):863-85. PubMed ID: 11772126
[TBL] [Abstract][Full Text] [Related]
18. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
[TBL] [Abstract][Full Text] [Related]
19. Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns.
Di Carlo C; Tommaselli GA; Gargano V; Savoia F; Bifulco G; Nappi C
Climacteric; 2010 Oct; 13(5):442-6. PubMed ID: 20575654
[TBL] [Abstract][Full Text] [Related]
20. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
Simon JA; Bouchard C; Waldbaum A; Utian W; Zborowski J; Snabes MC
Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
